Date: Tuesday 29th March 2022 Time: 12:00-13:00 BST Speakers: Amanda Darekar (Pfizer), Joanne Mann (Veramed) and Holly Tovey (Institute for Cancer Research).
Who is this event intended for? Statisticians at all levels. What is the benefit of attending? Learn about different career trajectories from Statisticians across the healthcare industry and expand your view on the role of 'Statistician'.
Registration
Registration for this webinar is free, and is open to Members of PSI only.
To register for this event, please click here.
Overview
Climbing the traditional Career Ladder has long been associated with career progression with the ultimate goal of moving into management. Statistics as a field has grown in prominence, especially in the last few years and with that growth we re-examine whether the traditional Career Ladder is still relevant.
Hear from others in the PSI Community who look to forge their own path in the industry as a Statistician. They will give their own personal views and experiences on creating your own career path.
Speaker details
Speaker
Biography
Joanne Mann (Veramed)
Joanne is a Principal level Statistician working at Veramed. She has over 25 years experience in the Pharmaceutical Industry, working as a project statistician and in project statistical oversight for Contract Research Organisations (including Covance, PharmaNet and inVentiv Health) and more recently for Pharma companies such as Eli Lilly. She has experience within both early and late phase clinical trials, and in a wide range of therapeutic areas including oncology.
Amanda Darekar (Pfizer)
Amanda has nearly 25 years’ experience in the industry. She started her career at Quintiles (now IQVIA) supporting a wide range of clients and projects, followed by a stint at Pharmacia, a mid-size pharmaceutical company, moving to Pfizer after its acquisition of Pharmacia in 2003.
Since then, Amanda has supported a wide range of projects spanning many therapeutic areas and phases, initially working on early development studies in neurology/pain and urology, and in 2007 Amanda undertook a year-long secondment to Pfizer India to manage a statistics group in Mumbai. Once back in the UK, she returned to supporting a variety of projects within urology and cardiovascular/metabolic therapeutic areas. Amanda is currently statistical program lead for two projects within the Internal Medicine Statistics Cluster.
Holly Tovey (Institute of Cancer Research)
Holly Tovey is a senior statistician and PhD student in the Clinical Trials and Statistics Unit at the Institute of Cancer Research. The aim of her thesis is the identification of biomarkers to predict response for emerging therapeutic agents for triple negative breast cancer. Her main areas of interest are machine learning and effective incorporation of biomarkers in clinical trials.
Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
The event will open with an overview on drug development in women’s health from a clinician perspective. This talk is followed by talks about statistical challenges when planning IVF studies and analysing the menstrual cycles.
This webinar will provide an overview of surrogacy for licensing and reimbursement. In turn, the need of extensions of the SPIRIT and CONSORT statement will be defined and outlined, with case studies to support.
Joint PSI/EFSPI Pre-Clinical SIG Webinar: Virtual Control Groups in Toxicity Studies
Lea Vaas will present how replacement of concurrent control animals by Virtual Control Groups (VCGs) in systemic toxicity studies may help in contributing to the 3R's principle of animal experimentation: Reduce, Refine, Replace.
Joint PSI/EFSPI Data Science SIG Webinar: Developing Digital Measures (Digital Biomarkers) in Drug Development – insights from Mobilise D consortium
We will share a brief overview of what Mobilise D is and why it is an important step stone in the development of digital biomarkers, and how Mobilise D outputs can be relevant for you.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
PSI Webinar: Development of Gene Therapies: Strategic, Scientific, Regulatory and Access Considerations
This webinar will cover the history of cell/gene therapy, major regulatory advances, the role of quantitative scientists in drug development of these novel therapeutics, and discuss opportunities for innovation and product advancement.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
PSI Introduction to Industry Training (ITIT) Course - 2024/2025
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
Statisticians in the Pharmaceutical Industry Executive Office: c/o MCI UK Ltd | Unit 24/22 South | Building 4000 | Langstone Park| Langstone Road | Havant | PO9 1SA | UK